You're staring at a spirometry report. The numbers swim. That's why fEV1. FEV1/FVC ratio. TLC. In real terms, rV. FVC. The doctor said "obstructive pattern" or maybe "restrictive pattern" — but what does that actually mean for your lungs, your treatment, your life?
Here's the thing: spirometry is the most common pulmonary function test on the planet. That's where things get fuzzy for most people. But the interpretation? Even some clinicians.
Let's clear it up.
What Is Spirometry and Why Does It Matter
Spirometry measures how much air you can move in and out of your lungs — and how fast. Simple in theory. Consider this: you take a maximal breath in, then blast it out as hard and fast as you can into a mouthpiece connected to a machine. Brutal in practice if your lungs don't cooperate That's the part that actually makes a difference..
The test spits out a handful of key numbers. The big three:
- FVC (Forced Vital Capacity) — total volume of air you can exhale forcefully after a maximal inhalation
- FEV1 (Forced Expiratory Volume in 1 second) — how much of that air you pushed out in the first second
- FEV1/FVC ratio — the percentage of your vital capacity you expelled in that first second
These three numbers are the Rosetta Stone for distinguishing obstructive from restrictive disease. But they don't tell the whole story. Not even close Easy to understand, harder to ignore. And it works..
The Obstructive Pattern: Airways That Won't Let Go
Obstructive lung disease means air gets in fine — but struggles to get out. The airways are narrowed, inflamed, floppy, or plugged with mucus. Think of a garden hose with a kink in it. Now, water goes in. Trickles out.
Classic examples: COPD (emphysema, chronic bronchitis), asthma, bronchiectasis, cystic fibrosis.
On spirometry, the hallmark is a reduced FEV1/FVC ratio. Usually below 0.70 (or below the lower limit of normal for age/sex/height). FVC might be normal or reduced. On top of that, fEV1 is disproportionately low. The curve on the flow-volume loop? Concave — scooped out like a spoon took a bite Nothing fancy..
But here's what trips people up: air trapping. In severe obstruction, you can't fully empty your lungs. Residual volume (RV) goes up. Total lung capacity (TLC) goes up. The lungs hyperinflate. Plus, that's why COPD patients get barrel chests. Their lungs are literally too big for their chest cavity.
The Restrictive Pattern: Lungs That Won't Expand
Restrictive lung disease is the opposite problem. Even so, the lungs can empty fast — they just can't fill properly. Day to day, the total volume is reduced. Think of a stiff balloon. Now, hard to blow up. Easy to deflate And that's really what it comes down to..
Causes fall into two buckets:
Intrinsic (parenchymal) disease — the lung tissue itself is scarred, inflamed, or infiltrated. Idiopathic pulmonary fibrosis (IPF), sarcoidosis, hypersensitivity pneumonitis, pneumoconioses (silicosis, asbestosis), ARDS It's one of those things that adds up..
Extrinsic (extraparenchymal) disease — something outside the lungs prevents expansion. Obesity, kyphoscoliosis, neuromuscular disease (ALS, myasthenia gravis), pleural effusion, pleural thickening, chest wall trauma.
On spirometry: FVC is reduced. FEV1 is reduced proportionally. The FEV1/FVC ratio is normal or even elevated (often >0.80). The flow-volume loop looks like a tiny, tall, narrow triangle — preserved shape, just shrunken Small thing, real impact..
But spirometry alone cannot confirm restriction. It can only suggest it. So you need lung volumes (body plethysmography, helium dilution, or nitrogen washout) to prove TLC is actually reduced. This is the single biggest diagnostic trap in pulmonary function testing.
Why This Distinction Changes Everything
You might wonder: does the label really matter? In real terms, short answer: yes. Profoundly And that's really what it comes down to..
Treatment Paths Diverge Immediately
Obstructive disease? On the flip side, bronchodilators. Inhaled corticosteroids (sometimes). Here's the thing — pulmonary rehab. Think about it: smoking cessation — non-negotiable. Also, biologics for severe eosinophilic asthma. Lung volume reduction surgery or valves for select emphysema patients. Transplant in end-stage The details matter here..
Restrictive disease? Completely different playbook. Think about it: antifibrotics (nintedanib, pirfenidone) for IPF. Still, immunosuppression for connective tissue disease-related ILD or sarcoidosis. Weight loss for obesity-related restriction. Even so, non-invasive ventilation for neuromuscular disease. Treating the underlying cause — draining a pleural effusion, fixing a flail chest. Transplant for end-stage fibrosis.
Give a restrictive patient a LABA/LAMA combo? Consider this: miss an obstructive component in a mixed picture? Waste of money, potential side effects. You've left treatable disease on the table.
Prognosis and Counseling Are Worlds Apart
COPD: progressive but often slow. Years to decades. Exacerbations drive mortality. Cardiovascular comorbidity is the silent killer.
IPF: median survival 3–5 years from diagnosis without antifibrotics. That's why faster than many cancers. Now, patients need to know this — not to terrify them, but to plan. Advance directives. Practically speaking, palliative care referral early. Transplant evaluation now, not later That's the part that actually makes a difference..
Sarcoidosis? Often self-limited. But cardiac or neurosarcoidosis changes the game entirely.
Obesity-related restriction? Even so, reversible. Plus, weight loss restores lung volumes. That's a conversation about hope, not just management Simple, but easy to overlook..
Disability, Work, and Quality of Life
Spirometry numbers drive disability determinations. On top of that, occupational medicine uses them for fitness-for-duty. On the flip side, the VA uses FEV1/FVC and TLC. Social Security uses FEV1 thresholds. A misclassified pattern can cost someone their benefits — or their job.
How Spirometry Actually Separates the Two (And Where It Fails)
Let's walk through the logic step by step. This is the part most guides rush through.
Step 1: Check Quality First
Before you interpret anything, look at the acceptability and repeatability criteria. But two best FVC values within 150 mL. No cough in first second. Good start-of-test (back-extrapolated volume <5% FVC or 150 mL). Three acceptable maneuvers. Two best FEV1 values within 150 mL. No glottis closure. Plus, no leak. Full exhalation (at least 6 seconds or 1-second plateau) That's the whole idea..
If quality is garbage, interpretation is garbage. Period.
Step 2: Look at FEV1/FVC Ratio
Below LLN (or <0.70 if using fixed ratio) → Obstructive pattern.
Normal or high → Not obstructive. Could be normal, restrictive, or mixed.
This is the fork in the road. Day to day, 70) overdiagnoses obstruction in older adults and underdiagnoses it in young people. Day to day, lLN (lower limit of normal) from reference equations (GLI 2012 is the gold standard) is far superior. But — and this is critical — the fixed ratio (0.Use it Simple, but easy to overlook..
Quick note before moving on.
Step 3: If Obstructive Pattern — Grade Severity by FEV1 % Predicted
- Mild: FEV1 ≥80% predicted
- Moderate: 50–79%
- Severe: 30–49%
- Very severe:
<30% The details matter here..
Then look at FEV1/FVC. Practically speaking, if it's reduced, you've confirmed obstruction. If it's preserved or elevated, you're dealing with restriction or a normal study But it adds up..
Step 4: Assess Bronchodilator Response
Give 400 mcg albuterol via nebulizer or 4 puffs MDI. Wait 15–20 minutes. Repeat spirometry Small thing, real impact..
A significant response: ≥12% and ≥200 mL improvement in FEV1 (and ideally FVC). This suggests reversibility — asthma, COPD with an asthmatic component, or allergic bronchopulmonary aspergillosis.
But here's what trips people up:
- A "negative" bronchodilator response doesn't rule out asthma. Some asthmatics are fixed obstruction by the time you test them.
- A "positive" response doesn't mean it's only asthma. COPD patients can have significant reversibility too — it doesn't change the diagnosis, it just means bronchodilators are worth continuing.
- Post-bronchodilator values are what you use for severity grading, not pre-bronchodilator. Document both, but grade on the post-BD numbers.
Step 5: If Not Obstructive — Evaluate for Restriction
Normal or high FEV1/FVC, but low FVC. Now you need TLC (total lung capacity) from body plethysmography or gas dilution Worth keeping that in mind..
TLC <80% predicted = True restriction.
TLC normal or high = Pseudorestriction. This happens in severe obstruction where air trapping reduces FVC artificially, making it look restrictive. The TLC is actually elevated. This is a critical distinction — treating pseudorestriction as true restriction leads you down the wrong diagnostic path entirely.
Step 6: If Restriction — Narrow the Differential
Low TLC with restriction asks: Why is the lung small?
- Parenchymal: Interstitial lung disease (IPF, NSIP, UIP, hypersensitivity pneumonitis). Check DLCO — it's usually reduced. High-resolution CT chest is your next move.
- Extrapulmonary (chest wall/pleural): Kyphoscoliosis, obesity, pleural effusion, ankylosing spondylitis. DLCO is often normal because the lung parenchyma itself is fine — it's just being compressed.
- Neuromuscular: Diaphragm weakness, myasthenia gravis, ALS. Look for low maximal inspiratory pressure (MIP), reduced SNIP, or paradoxical breathing on flow-volume loop.
- Upper airway: Vocal cord dysfunction, tracheal stenosis. Flow-volume loop shows flattening of the inspiratory limb (extrathoracic) or expiratory limb (intrathoracic).
Step 7: Consider Mixed (Obstructive + Restrictive)
Reduced FEV1/FVC and reduced FVC. But TLC is also reduced. This is mixed — both components are real.
- COPD with concurrent ILD (smoking-related ILD + emphysema — the "combined pulmonary fibrosis and emphysema" or CPFE syndrome)
- Sarcoidosis (can be both)
- Asbestosis with smoking history
Treat both components. Missing the obstructive part in a patient with IPF means you miss a bronchodilator-responsive element. Missing the restrictive part in a COPD patient means you miss a competing diagnosis that changes trajectory That's the whole idea..
Where Spirometry Fails
Let's be honest about its limitations.
Small airway disease. Spirometry detects obstruction when it involves the larger airways. Early small airways disease — the kind you see in early COPD, vaping-related injury, or occupational exposures — can be completely normal on spirometry. You need IOS (impulse oscillometry), nitrogen washout, or CT to catch it Nothing fancy..
Isolated DLCO abnormalities. A patient with normal spirometry but a tanked DLCO — that's a clue. Pulmonary vascular disease, early emphysema, anemia, or pulmonary hypertension can all lurk behind a normal spirometry curve.
Obesity. BMI >40 can suppress FVC and FEV1 without true parenchymal disease. TLC may be normal — making it pseudorestriction or just reduced ventilatory capacity from mechanical loading. Don't overcall restriction here Nothing fancy..
Poor effort. The most common "abnormality" in experienced
hands is poor effort. And the most common "abnormality" in experienced hands is poor effort. And if the two best FVCs aren't within 150 mL, or the back-extrapolated volume exceeds 5% of FVC or 150 mL, the data is suspect. Always check the acceptability and repeatability criteria (ATS/ERS 2019 standards). Submaximal inhalation, early termination, coughing during the maneuver, or a hesitant start — all produce curves that mimic disease. Don't interpret garbage.
Pediatric and geriatric nuances. Children under 6 often can't perform forced maneuvers reliably. In the elderly, cognitive impairment, dentures, or comorbidities may limit cooperation. Reference equations matter — using NHANES III for a 90-year-old or GLI equations for a population they weren't validated in introduces systematic error.
Quality Control: The Invisible Backbone
A PFT lab without rigorous quality control is a random number generator. That said, daily calibration checks with a 3-L syringe. Quarterly linearity verification. Consider this: annual peer review of tracings. Technologist competency assessments. If your lab can't show you their QC logs, don't trust their numbers And that's really what it comes down to. Surprisingly effective..
Putting It All Together: The Clinical Synthesis
Spirometry is a snapshot. The patient is a movie That's the part that actually makes a difference..
A 58-year-old former smoker with dyspnea on exertion. Which means 68, FEV1 62% predicted, FVC 78% predicted, TLC 105% predicted, RV 135% predicted, DLCO 48% predicted. Spirometry: FEV1/FVC 0.Post-bronchodilator FEV1 improves 14% and 220 mL Worth keeping that in mind..
This is moderate obstructive defect with significant air trapping and disproportionately reduced DLCO. Now, the bronchodilator response is significant but incomplete. The low DLCO out of proportion to airflow limitation suggests emphysema-predominant COPD or combined pulmonary fibrosis and emphysema (CPFE) — get a CT. Also, the air trapping (elevated RV/TLC) explains the dyspnea better than the FEV1 alone. This patient needs long-acting bronchodilators, pulmonary rehab, smoking cessation reinforcement (if still smoking), and CT evaluation for structural correlates.
Same numbers, different context: 32-year-old woman, never-smoker, childhood asthma. Think about it: tLC normal. DLCO normal. Still, this is asthma with persistent airflow limitation — likely airway remodeling. Post-bronchodilator FEV1 normalizes. Different prognosis, different monitoring, different conversation.
The Final Principle
Spirometry doesn't make diagnoses. Clinicians make diagnoses using spirometry.
The numbers are constraints. A reduced FEV1/FVC in a patient with heart failure and pulmonary edema isn't COPD. Which means they narrow the universe of possibilities. But the history, the exam, the imaging, the biomarkers, the trajectory over time — that's where the diagnosis lives. A "normal" spirometry in a patient with exertional hypoxia and a CT full of ground-glass opacities isn't reassuring.
Respect the physiology. On the flip side, master the patterns. Question the outliers. And never, ever treat the number instead of the patient.
